Comparison

HPK1-IN-9 European Partner

Item no. HY-145035-1ea
Manufacturer MedChem Express
CASRN 2734168-78-4
Amount 1 ea
Quantity options 100 mg 1 ea
Category
Type Chemicals
Specific against other
Formula C30H33N7O2
Citations [1]Xie, Yuli, et al. Hpk1 inhibitor and preparation method and use thereof. Patent WO2021213317A1.
Smiles O=C(N1CC(C1)N(C)C)C2=CC=C(C3=CNC4=C3N=C(C5=CC=C6C(OCC7N6CCN(C7)C)=C5)C=N4)C=C2
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
HPK1-IN-9 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-9 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 112) [1].
Shipping
Room temperature
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
523.63
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer; Inflammation/Immunology
Solubility
10 mM in DMSO
Target
MAP4K
Manufacturers Target
MAP4K
Manufacturers Pathway
MAPK/ERK Pathway
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close